Evaluation for NCI Surgery Branch Clinical Studies

This study is currently recruiting participants.
Verified July 2012 by National Institutes of Health Clinical Center (CC)
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00001823
First received: November 3, 1999
Last updated: August 22, 2012
Last verified: July 2012

November 3, 1999
August 22, 2012
June 1999
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00001823 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Evaluation for NCI Surgery Branch Clinical Studies
Evaluation for NCI Surgery Branch Clinical Research Protocols

Patients with a suspected or proven malignant disease (cancer) will be admitted to this study to be evaluated for suitability in a clinical trial of the National Cancer Institute's Surgery Branch.

No experimental treatments will be administered in this study; its purpose is solely to evaluate patients for eligibility in other NCI Surgery Branch trials. In rare cases, patients who are ineligible for a current study may nevertheless be admitted for standard treatment because their condition represents a unique training or research experience.

Patients will undergo various tests and procedures, depending on the study for which they are being considered. The tests may include, but not be limited to, various blood tests, such as HLA tissue typing and hepatitis screening; imaging tests such as PET, MRI and CT scans, and procedures such as pulmonary function tests, arteriogram, tumor biopsy, and laparoscopy.

Background:

Potential research candidates undergo thorough screening including laboratory tests, scans, x-rays and review of pathology slides to determine initial eligibility for Surgery Branch research protocols.

Objectives:

To permit evaluation of patients referred to the NCI Surgery Branch in order to identify individuals who will be suitable candidates for Surgery Branch clinical research protocols.

Eligibility:

Patient suspected of having, or with biopsy proven malignant disease.

Patient, parent or guardian (if a minor), is able to provide informed consent.

Design:

Patients enrolled on this protocol will be evaluated by NCI Surgery Branch physicians to determine the individual's suitability for participation in a clinical research protocol. An accrual ceiling of 5000 patients has been set to meet the screening needs of the Surgery Branch.

Observational
Not Provided
Not Provided
Not Provided
Not Provided
Not Provided
Cancer
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
5000
Not Provided
Not Provided
  • INCLUSION CRITERIA:

Patients suspected of having, or with biopsy proven malignant disease.

Patient, parent or guardian (if a minor), is able to provide informed consent.

EXCLUSION CRITERIA:

Candidates who do not meet the inclusion criteria.

Both
16 Years and older
No
Contact: June Kryk, R.N. (301) 451-1929 ncisbirc@mail.nih.gov
Contact: Steven A Rosenberg, M.D. (301) 496-4164 sar@mail.nih.gov
United States
 
NCT00001823
990128, 99-C-0128
Not Provided
Not Provided
National Cancer Institute (NCI)
Not Provided
Principal Investigator: Steven A Rosenberg, M.D. National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
July 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP